GLP-1 Medications for Kids: Do They Work, and at What Price?

Authors

• Sylvia Pena, Marquette University
• Marilyn Frenn, Marquette UniversityFollow

Document Type

Article

Publication Date

12-2025

Publisher

BMJ Publishing Group

Source Publication

Evidence-Based Nursing

Source ISSN

1367-6539

Abstract

Implications for practice and research

• Findings demonstrated that glucagon-like peptide-1 receptor agonist medications improved diabetes and weight outcomes without significant side effects.

• This meta-analysis1 was government funded, but 10 of the 18 studies included were funded in whole, seven in part by pharmaceutical companies, so research independent of the companies would be an asset, along with comparative effectiveness and cost studies with bariatric surgery.

Comments

Accepted version. Evidence-Based Nursing (2025): 1-3. DOI. © 2025 BMJ Publishing Group. Used with permission.

Recommended Citation

Pena, Sylvia and Frenn, Marilyn, "GLP-1 Medications for Kids: Do They Work, and at What Price?" (2025). College of Nursing Faculty Research and Publications. 1098.
https://epublications.marquette.edu/nursing_fac/1098